Red Light vs Near-Infrared Dose: Why Multi-Wavelength Panels Need Band-Split Joules

Update date: 2026.5.20 | Reading time: 13 minutes

This article focuses on product design and reporting logic for multi-wavelength panels. It is not a treatment protocol guide.

Imagine three red light panels side by side. All three are honest. All three publish exactly the same headline: 57 J/cm² total surface dose at 15 cm in a 10-minute session. A buyer picks the cheapest one, assuming "same dose, same outcome."

The buyer has just made a mistake that no amount of irradiance testing will fix. Because the three panels split that 57 J/cm² very differently:

• Panel A: 24 J/cm² red + 33 J/cm² near-infrared
• Panel B: 45 J/cm² red + 12 J/cm² near-infrared
• Panel C: 8 J/cm² red + 49 J/cm² near-infrared

These are not minor variations of the same product. They are engineered for different tissue depths and different application categories. The "total joule" number on the box is a sum that quietly throws away the most important information about what the panel is actually designed for.

This article is about that missing information. It explains why red (around 620–680 nm) and near-infrared (roughly 800–1100 nm) photons behave differently once they enter skin, why a single "total dose" number hides product design intent, and what a credible multi-wavelength panel report should look like.

If you want the underlying dose math — what a joule is, how mW/cm² becomes J/cm², or how testing distance changes the curve — those are covered in our companion guides linked at the end. This piece stays on one question: why red joules and NIR joules are not interchangeable, and why "total output" is the wrong way to compare multi-wavelength panels.

Red and near-infrared should not be treated as interchangeable engineering inputs

Red light and near-infrared light get talked about as if they were two flavours of the same thing. They are not. They are two different engineering inputs that happen to be delivered by the same kind of device.

The simplest way to see this is to look at where the photons actually go.

A red photon at around 660 nm is absorbed strongly by haemoglobin and by the upper layers of skin. Its energy is generally more concentrated in superficial tissue layers — the depth range that includes the dermis, the hair follicle bulge, the small blood vessels of the papillary plexus, and the upper edge of subcutaneous tissue. Red is, by physics, a superficial-tissue engineering input.

A near-infrared photon at 810 or 850 nm sits in the so-called optical window of biological tissue — the range from roughly 650 to 1100 nm where absorption by haemoglobin has dropped and absorption by water has not yet risen sharply. Photons in this window penetrate further. By 850 nm, the light is generally associated with deeper tissue exposure than visible red light. NIR is a deeper-tissue engineering input.

These depth descriptions are simplified engineering references, not fixed biological cutoffs. Actual tissue penetration depends on skin tone, tissue type, beam geometry, contact conditions, and measurement method.

That single difference cascades into everything downstream. A panel designed for dermal exposure profiles is not the same panel as one designed for deeper musculoskeletal exposure profiles. They have different LED ratios, different driver designs, often different lens choices — and they need different J/cm² figures reported for each band. The device output literally is not the same photon population.

red-vs-nir-penetration-depth

A "total dose" figure averages across this difference and erases it.

Why the specific wavelength matters at the molecular level

The deeper reason red and NIR are not interchangeable is that the molecular target inside the cell — the chromophore — does not absorb equally across the spectrum.

The most studied photoacceptor referenced in photobiomodulation research is cytochrome c oxidase, the terminal enzyme of the mitochondrial electron transport chain. Its absorption spectrum is not flat. It has peaks centred near 620–680 nm, near 760–830 nm, and a broader band extending past 900 nm. These peaks are why specific wavelengths — 630, 660, 810, 830, 850 — keep appearing in the PBM literature instead of, say, 720 or 870. Researchers have converged on the wavelengths the molecule shows the strongest response to.

There are other chromophores, too. Water itself absorbs increasingly strongly past about 950 nm, with a clear peak near 980 nm. Membrane-bound channels and certain pigments have their own preferences. And the emerging research interest in 1060–1070 nm is partly because that range sits in a relatively low-water-absorption pocket between the strong 980 nm water peak and the next water absorption band — a "second window" where photons can travel further than at 850 nm.

The practical upshot for product design is straightforward. A red joule at 660 nm and a near-infrared joule at 850 nm do not arrive at the same place in the body, do not interact with the same molecules in the same way, and do not produce the same downstream optical signature. They are both legitimate inputs for PBM research and product design. They are not substitutes for each other.

A spec sheet that adds them into a single number is doing something equivalent to a parts list that adds milligrams of two different materials into one "total weight" — a quantity that is technically correct but not useful for serious product comparison.

The four wavelength neighbourhoods that actually matter

Modern multi-wavelength panels are not random spectral cocktails. Manufacturers choose specific LED part numbers for specific reasons. There are essentially four neighbourhoods on the spectrum where commercial red light therapy products cluster, and each has a different engineering rationale.

620–680 nm — the red band. This is the visible-red region. 630 nm and 660 nm are the most common choices. The light is absorbed by haemoglobin and reaches the dermis and immediate sub-dermal layers. It is the band most often referenced in surface-level PBM research contexts — skin appearance, hair-follicle research, and superficial tissue work. It is also the band the user actually sees, which has its own value: visible red gives the user a perceptual confirmation that the device is on and aimed correctly. A panel that ships with no visible red at all — pure NIR — feels broken to most users, even when the NIR is doing real work.

800–900 nm — the NIR-1 workhorse band. 810, 830, and 850 nm dominate the published PBM literature for deeper-tissue research: musculoskeletal recovery research, transcranial PBM research, and peripheral nerve research. 810 nm is the wavelength used in most transcranial PBM research. 850 nm is the dominant LED choice for full-body and sports-recovery panels because high-output, narrow-spectrum 850 nm LEDs are widely available and well-binned. If a panel reports a "near-infrared" number with no further specification, this band is almost always where the photons are.

930–950 nm — the deep but watery band. 940 nm LEDs exist and are sometimes added to multi-band panels for marketing breadth, but the physics is harder here. Water absorption is climbing toward its 980 nm peak, which means more of the energy is absorbed shallowly as heat rather than reaching deeper tissue layers. 940 nm is a defensible choice in some designs, but a panel that allocates a large share of its budget to 940 nm is making an unusual call that should be backed by an explicit rationale.

1050–1070 nm — an emerging area of interest. This is an area of growing research interest, and where multi-wavelength panel design is starting to differentiate. Photons in the 1060–1070 nm range sit in a relatively low-water-absorption pocket and may offer a different absorption and penetration profile than 850 nm. Brain PBM researchers have published on 1064 nm specifically. Product claims in this band should be supported by wavelength-specific measurement and application-specific evidence. The engineering catch is that 1060–1070 nm LEDs are more expensive, less widely binned, and harder to characterise — most low-cost spectroradiometers do not measure cleanly past 1000 nm. A panel that legitimately delivers 1060 nm output is making an engineering investment that a typical "660 + 850" panel is not.

four-wavelength-neighborhoods

These four neighbourhoods are how a credible multi-wavelength panel is designed: not "more wavelengths is better," but "this band for this depth zone, this band for this chromophore peak, this ratio because of the intended use case." A buyer reading a spec sheet should be able to recognise the design intent. A spec sheet that just lists "multi-wavelength" without per-band irradiance and per-band dose is hiding whether there is any intent at all.

The band-dose formula and what a real report looks like

The math is the same equation that applies to any single-band calculation, just applied separately to each band:

Band Dose = E_band × t ÷ 1000

Where E_band is the irradiance in mW/cm² for that wavelength band (red, NIR-1, NIR-2, etc.) and t is the session length in seconds. The divide-by-1000 is the milliwatt-to-watt conversion.

If a panel's red mW/cm² is 40 at 15 cm and its NIR mW/cm² is 55, a 600-second session deposits 24 J/cm² of red and 33 J/cm² of NIR at the skin. Each number is the dose for that band, and both numbers belong on the spec sheet.

For panels that include a third or fourth band — say red + 850 + 1060 — the report should list each one. The form is repetitive but informative:

band-dose-formula-report

A report in this form is auditable. A buyer can see exactly how much energy is going into each depth zone and check whether the ratio matches the panel's stated use case. A report that says only "52 J/cm² in 10 minutes" gives the user a slogan, not a specification.

For an extraction of individual bands from a spectroradiometer trace, the more general form is:

E_band = ∫ E(λ) dλ

— integrate the spectral irradiance over the wavelength range that defines the band. Spectroradiometers like the OHSP-350-IRF series can export per-nanometre data straight to Excel, which lets a serious lab compute red (e.g. 620–680 nm), NIR-1 (800–900 nm), and NIR-2 (940–1070 nm) totals from a single measurement. That is the level of detail a private-label brand or clinic-grade buyer should expect.

Three panels, same total, three different products

Go back to the three panels from the opening. All three quote 57 J/cm² total in 10 minutes. The honest version of their spec sheets looks like this:

A spa buyer who wants a facial-positioned panel and ends up with Panel C has bought the wrong product, no matter how impressive "57 J/cm²" looked. A rehab clinic that wants to support deeper musculoskeletal exposure and ends up with Panel B is delivering most of its dose to superficial layers and leaving the intended target zone under-exposed. Both buyers will feel that the panel "works" — visible red is warm and pleasant, and any LED radiation produces some user-perceived response — but neither will be matching the band-split profile their actual application calls for.

This is why the total-output framing is dangerous. It lets three completely different products compete on the same headline number, and it lets manufacturers avoid disclosing the engineering choice that actually defines what their panel is.

Picking a band ratio: matching design to use case

Once the buyer accepts that the ratio matters as much as the total, the natural next question is "what ratio fits the product positioning?" The honest answer is: it depends on the application category, and any manufacturer who claims one ratio is universally best is selling.

The following ratios are product-positioning references, not treatment protocols. They reflect where the published research literature concentrates rather than any individual study or clinical recommendation:

• Skin, hair, fine lines, redness positioning. Red-heavy. The intended exposure depth is shallow; the chromophore interaction discussed in PBM literature occurs in the dermis and the upper sub-dermal layers. Panels with 1.5:1 to 2:1 red-to-NIR ratios are common for this category.
• General wellness, recovery, mixed-use positioning. Roughly balanced — 1:1 to 1:1.5 — because the product is positioned across both superficial and deeper exposure zones. This is the most common consumer-panel configuration.
• Joint, deeper muscle, post-exercise recovery positioning. NIR-heavy. The intended application is usually associated with deeper tissue exposure than the dermis. Panels in this category often run 1:2 to 1:3 red-to-NIR ratios, and may add a third NIR-2 band for additional depth.
• Transcranial / neuro research devices (not consumer products). Heavily NIR, often centred on 810 nm specifically because that wavelength has the strongest published research base for skull-penetrating PBM.
• Emerging multi-wavelength designs. Some new products add a 1060–1070 nm band on top of red + 850 nm specifically to extend the deeper-exposure portion of the spectrum while keeping the surface dose in a sensible window. This is the area where multi-band panels are starting to differentiate meaningfully from "more LEDs, same wavelengths" designs.

These are orientation values for product positioning, not protocols. The structural point is this: the right ratio is a design decision tied to a use case, and the spec sheet should reflect it. A panel marketed for face and skin use that runs 1:3 red-to-NIR is mismatched to its claim. A panel marketed for athletic recovery that runs 2:1 red-to-NIR is the same kind of mismatch in reverse.

What to ask a supplier about band design

Buyers evaluating a multi-wavelength panel — whether for a clinic, a private-label launch, or a serious personal purchase — can shortcut almost the entire conversation by asking five questions. A capable supplier answers all five from a data sheet they already have. An incapable supplier hesitates or improvises.

1. What are the peak wavelengths and half-width of each band? Not "red and NIR" — the actual LED part numbers, or at minimum the centroid and full-width-at-half-max of each emission band. A panel claiming "850 nm" with a 30 nm half-width is delivering some 870 nm photons and some 830 nm photons. That is not wrong, but it should be on the page.

2. What is the irradiance of each band, separately, at the stated test distance? A combined "95 mW/cm²" number is incomplete. Each band needs its own irradiance figure measured under the same conditions, on the same grid, after the same preheat.

3. What is the dose of each band, calculated for a stated session length? Multiplying band irradiance by time should give a band-specific J/cm² number. All bands listed. Total at the bottom as a sum, not as the lead number.

4. What is the design intent of this ratio? A supplier who has thought about this will say "we designed this panel red-heavy because the primary positioning is skin and superficial work" or "we biased NIR because this is a recovery and deeper-tissue panel." A supplier who has not will give an evasive answer. Both responses are informative.

5. Can the bands be controlled independently? Many modern panels offer red-only, NIR-only, and combined modes. This matters because some application categories are best matched by red alone (e.g., delicate facial positioning) or NIR alone (e.g., targeted deeper-tissue positioning), and a panel with only one combined mode forces every session to be the same blend. Independent control adds engineering cost but expands the panel's usable application range.

Five questions, and the supplier shortlist filters itself.

Bottom line

A total joule number on a multi-wavelength panel is the spectrum's average shadow on a single dimension. It is a real number — and it is the wrong number to compare panels by. Red and near-infrared photons enter the body at different depths, interact with different chromophores, and contribute to different optical signatures. The choice to deliver more red, more NIR, or to add a 1060 nm band is what defines the panel as a product. Hiding that choice inside a "total output" sum hides the only spec that matters for matching the device to its intended application category.

The format that fixes this is not complicated:

• A peak wavelength and band width for every LED type on the board.
• An irradiance number for every band, at a stated distance, on a stated grid, after stated preheat.
• A J/cm² figure for every band at a stated session length.
• A total below the per-band figures, not in place of them.

A red light therapy industry that publishes at this level competes on engineering. An industry that publishes only totals competes on marketing. Multi-wavelength panels in particular live or die on this distinction — they are the products with the most to disclose, and the products where vague disclosure does the most damage.

For any private-label brand, clinic, or buyer comparing what looks like equivalent panels: the joule number is half the question. The band breakdown is the other half. Ask for both.

Request a band-split dose report from REDDOT LED for red, NIR-1, and NIR-2 wavelength configurations — with per-band irradiance, per-band J/cm², and the design rationale behind the chosen ratio.

Companion guides

You may also find these helpful:

• What Are Joules in Red Light Therapy? Why Dose Matters More Than Watts and LED Count
• Joules vs Irradiance: Why mW/cm² Is Just the Starting Point, Not Your Final Red Light Therapy Dose
• How to Calculate Red Light Therapy Dose: A Practical Guide from mW/cm² to J/cm²
• Why Red Light Therapy Panels Should Not Be Judged by Wattage and LED Count
• Why do testing distance and uniformity alter the joule dosage of red light therapy devices?

References

• Mitochondrial signaling in mammalian cells activated by red and near-IR radiation
  https://pubmed.ncbi.nlm.nih.gov/18651871/
• Wang Y, Huang YY, Wang Y, Lyu P, Hamblin MR. Photobiomodulation (blue and green light) encourages osteoblastic-differentiation of human adipose-derived stem cells. Scientific Reports, 2017.
  https://www.nature.com/articles/srep33719
• Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 2017.
  https://pmc.ncbi.nlm.nih.gov/articles/PMC5523874/
• Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The Nuts and Bolts of Low-level Laser (Light) Therapy. Annals of Biomedical Engineering, 2012.
  https://pmc.ncbi.nlm.nih.gov/articles/PMC3288797/
• Huang YY, Chen ACH, Carroll JD, Hamblin MR. Biphasic Dose Response in Low Level Light Therapy. Dose-Response, 2009.
  https://pubmed.ncbi.nlm.nih.gov/20011653/
• Salehpour F, Mahmoudi J, Kamari F, Sadigh-Eteghad S, Rasta SH, Hamblin MR. Brain photobiomodulation therapy: a narrative review. Molecular Neurobiology, 2018.
  https://pubmed.ncbi.nlm.nih.gov/29327206/
• Light Therapy Insiders. The $2,500 Gadget I Use to Test Red Light Therapy Devices. 2025.
  https://www.lighttherapyinsiders.com/

This article is for educational and engineering reference only and does not constitute medical advice. For specific therapeutic applications, consult published clinical literature and a qualified healthcare professional.

Reposting requires indicating the source.